Yarrow Bioscience Inc. Company Profile
NASDAQ: YARWHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Yarrow Bioscience at a glance
Yarrow Bioscience Inc. (NASDAQ: YARW) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in New York, NY. Yarrow Bioscience is led by Ms. Rebecca Velez Frey Pharm.D. and employs about 7 people. The company's shares have traded publicly since 2018.
At a market capitalization of $184.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001566044, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Yarrow Bioscience do?
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company's candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Yarrow Bioscience Inc.
- Ticker
- NASDAQ: YARW
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Ms. Rebecca Velez Frey Pharm.D.
- Employees
- 7
- Headquarters
- 40 10 th Avenue, New York, NY, United States
- Phone
- (203) 433-7577
- Website
- yarrowbioscience.com
- IPO year
- 2018
- Market cap
- $184.88M
- SEC CIK
- 0001566044
- Latest annual report
- 10-K · Feb 27, 2026
Companies similar to Yarrow Bioscience
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ADAGAdagene Inc. ADR | 2.76 | -0.72% | $185.32M | vs YARW |
| NGENNervGen Pharma Corp. | 1.73 | -1.14% | $186.01M | vs YARW |
| PEPGPepGen Inc. | 2.62 | +10.08% | $181.22M | vs YARW |
| ORMPOramed Pharmaceuticals Inc. | 4.33 | +3.10% | $180.12M | vs YARW |
| VRXAVeraxa Biotech AG | 1.26 | +15.60% | $178.17M | vs YARW |
| DERMJourney Medical Corporation | 6.31 | +6.05% | $178.10M | vs YARW |
| ALXOALX Oncology Holdings Inc. | 1.25 | +5.93% | $172.85M | vs YARW |
| WHWKWhitehawk Therapeutics Inc. | 3.52 | +1.44% | $200.67M | vs YARW |